Estrogen-receptor biology: continuing progress and therapeutic implications.
Osborne
C Kent
CK
Breast Center, Baylor College of Medicine, One Baylor Plaza, BCM 600 Houston, TX 77030, USA. kosborne@breastcenter.tmc.edu
Schiff
Rachel
R
D000970:Antineoplastic Agents / Q000378:metabolism / Q000627:therapeutic use*; D047072:Aromatase Inhibitors / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy / Q000235:genetics / Q000378:metabolism; D005260:Female; D018773:Genes, erbB-1 / Q000187:drug effects / Q000235:genetics / Q000502:physiology; D018734:Genes, erbB-2 / Q000187:drug effects; D006801:Humans; D011960:Receptors, Estrogen / Q000235:genetics / Q000378:metabolism / Q000502:physiology; D020845:Selective Estrogen Receptor Modulators / Q000627:therapeutic use; D015398:Signal Transduction / Q000187:drug effects / Q000502:physiology; D013629:Tamoxifen / Q000627:therapeutic use
D000970:Antineoplastic Agents; D047072:Aromatase Inhibitors; D011960:Receptors, Estrogen; D020845:Selective Estrogen Receptor Modulators; D013629:Tamoxifen